rHb-based therapeutics (Apex)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NamerHb-based therapeutics (Apex)
Drug Alias Namerecombinant hemoglobin (Apex)rHb (Apex)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHemoglobins modulators
TargetsHemoglobins
Therapy Area/IndicationsShock
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAjinomoto Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApex Bioscience Inc
Active IndicationsN/A
Inactive IndicationsShock

Other Information

ATC CodeN/A
Related LinksN/A